Esmolol patient counseling information: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Patient Counseling Information== | ==Patient Counseling Information== | ||
Physicians should inform patients of the risks associated with BREVIBLOC injection: | Physicians should inform patients of the risks associated with BREVIBLOC injection: | ||
The most common adverse reactions are symptomatic [[hypotension]] ( [[hyperhidrosis]], [[dizziness]] ), and asymptomatic hypotension.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | The most common adverse reactions are symptomatic [[hypotension]] ([[hyperhidrosis]], [[dizziness]]), and asymptomatic hypotension.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Revision as of 00:02, 21 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Patient Counseling Information
Physicians should inform patients of the risks associated with BREVIBLOC injection: The most common adverse reactions are symptomatic hypotension (hyperhidrosis, dizziness), and asymptomatic hypotension.[1]
References
Adapted from the FDA Package Insert.